Pretreatment intratumoral susceptibility signals correlate with response to high-dose methotrexate and progression-free survival in primary central nervous system lymphoma

Author:

Deguchi Shoichi,Nakashima Kazuaki,Muramatsu Koji,Mitsuya Koichi,Oishi Takuma,Shirata Kensei,Hayashi Nakamasa,Sugino Takashi,Endo Masahiro,Nakasu Yoko

Publisher

Elsevier BV

Subject

Physiology (medical),Clinical Neurology,Neurology,General Medicine,Surgery

Reference41 articles.

1. Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy;Motomura;Leukemia Lymphoma,2011

2. Primary CNS lymphoma;Grommes;J Clin Oncol Off J Am Soc Clin Oncol,2017

3. Primary central nervous system lymphoma: a retrospective study;Tseng;J Clin Neurosci Off J Neurosurg Soc Austr,1998

4. Central nervous system lymphoma in immunocompetent patients: the North Shore-Long Island Jewish Health System experience;Zhang;J Clin Neurosci Off J Neurosurg Soc Austr,2013

5. Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study;Houillier;J Neurooncol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3